000 01172 a2200349 4500
005 20250511223502.0
264 0 _c19910212
008 199102s 0 0 eng d
022 _a0735-7907
024 7 _a10.3109/07357909009012071
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMahjoubi, M
245 0 0 _aPhase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.
_h[electronic resource]
260 _bCancer investigation
_c1990
300 _a477-81 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAged
650 0 4 _aDrug Administration Schedule
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMesna
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aSurvival Analysis
700 1 _aAzab, M
700 1 _aGhosn, M
700 1 _aTheodore, C
700 1 _aDroz, J P
773 0 _tCancer investigation
_gvol. 8
_gno. 5
_gp. 477-81
856 4 0 _uhttps://doi.org/10.3109/07357909009012071
_zAvailable from publisher's website
999 _c2131092
_d2131092